⌘K
t
NatWest Group plc purchased a total of 823,055 of its ordinary shares, with a nominal value of £1.0769 each, from UBS AG, London Branch, between 18 May 2026 and 21 May 2026. These transactions, part of an existing share buyback programme, occurred at prices ranging from 557.20 GBp to 572.0000 GBp per share. Following settlement, NatWest Group plc will hold 182,057,726 Ordinary Shares in treasury and have 7,973,679,077 Ordinary Shares in issue, with the intention to cancel the repurchased shares.
| Date | 22 May 2026 |
| Time | 18:02:57 |
| Category | Capital structure |
| ID | 5369F |
|
|
|
|
|
|
|
|
|
|
NatWest Group plc |
|
|
|
|
|
|
|
22 May 2026 |
|
|
|
|
|
|
|
Transaction in Own Shares |
|
|
|
|
|
|
|
NatWest Group plc (the 'Company') announces that, over the past week, it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). |
|||||
|
|
|
|
|
|
|
|
|
|
Aggregated information: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of purchase |
Number of Ordinary Shares purchased |
Highest price paid: (GBp) |
Lowest price paid: (GBp) |
Volume weighted average price paid per share (GBp) |
Venue |
|
|
18 May 2026 |
283,658 |
562.8000 |
557.40 |
559.2774 |
LSE |
|
|
18 May 2026 |
74,716 |
562.0000 |
557.60 |
559.3069 |
CHIX |
|
|
18 May 2026 |
31,189 |
561.0000 |
557.20 |
558.8724 |
BATE |
|
|
19 May 2026 |
52,000 |
566.0000 |
565.60 |
565.9291 |
LSE |
|
|
19 May 2026 |
16,979 |
566.0000 |
565.80 |
565.9416 |
CHIX |
|
|
19 May 2026 |
8,004 |
566.0000 |
565.80 |
565.9367 |
BATE |
|
|
20 May 2026 |
228,241 |
567.8000 |
560.00 |
565.1472 |
LSE |
|
|
20 May 2026 |
77,859 |
567.8000 |
562.00 |
565.2402 |
CHIX |
|
|
20 May 2026 |
35,593 |
567.6000 |
562.00 |
564.5299 |
BATE |
|
|
21 May 2026 |
8,857 |
572.0000 |
571.60 |
571.8738 |
LSE |
|
|
21 May 2026 |
3,400 |
572.0000 |
572.00 |
572.0000 |
CHIX |
|
|
21 May 2026 |
2,559 |
571.8000 |
571.80 |
571.8000 |
BATE |
|
|
|
|
|
|
|
|
|
|
* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share |
|
||||
|
|
Such purchases form part of the Company's existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 16 February 2026, as announced on 16 February 2026. |
|||||
|
|
|
|
|
|
|
|
|
|
The Company intends to cancel the repurchased Ordinary Shares. |
|
||||
|
|
|
|
|
|
|
|
|
|
Following the settlement of the above transactions, the Company will hold 182,057,726 Ordinary Shares in treasury and have 7,973,679,077 Ordinary Shares in issue (excluding treasury shares). |
|||||
|
|
|
|
|
|
|
|
|
|
Further information: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Relations |
|
|
|
|
|
|
|
+ 44 (0)207 672 1758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media Relations |
|
|
|
|
|
|
|
+44 (0)131 523 4205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal Entity Identifier: 2138005O9XJIJN4JPN90 |
|
|
|
||
|
|
|
|
|
|
|
|
|
|
Transaction details: |
|
|
|
|
|
|
|
In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme relating to the Transactions is detailed in the attached: http://www.rns-pdf.londonstockexchange.com/rns/5369F_1-2026-5-22.pdf |
|||||
|
|
|
|
|
|
|
|